Upfront cranial RT seems to show better efficacy, but whether it can improve the intracranial DCR and prolong the iPFS or OS for EGFRm NSCLC patients with BM treated with first‐ or second‐generation EGFR TKIs needs further study. This evidence concerns the gene EGFR and non-small cell lung carcinoma.